The evaluation of the COX-2 selective inhibition of lumiracoxib, a novel nonsteroidal antiinflammatory drug.

被引：1

作者：

Furuie, H ^{[1
]}

Murakami, M ^{[1
]}

Matsuguma, K ^{[1
]}

Ishibashi, M ^{[1
]}

Tsukikawa, H ^{[1
]}

Kimura, M ^{[1
]}

Shishido, A ^{[1
]}

Irie, S ^{[1
]}

机构：

[1] Novartis Pharma KK, Kyushu Clin Pharmacol Res Clin, Fukuoka, Japan

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期

关键词：

D O I：

10.1016/j.clpt.2003.11.016

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：P5 / P5

页数：1

共 50 条

[31] Computer-aided drug design of optimal ratio selective inhibition of COX-1 and COX-2
Madhavi, M.
Ramesh, M.
Arunapriya, L.
Parthasarathy, T.
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2016, 55 (08): : 1026 - 1034
[32] Lumiracoxib - A COX-2 inhibitor for the treatment of arthritis and acute pain
Feret, B
FORMULARY, 2003, 38 (09) : 529 - +
[33] COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs
Moore, BC
Simmons, DL
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (11) : 1131 - 1144
[34] Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine
Gross, GJ
Moore, J
PHARMACOLOGY, 2004, 71 (03) : 135 - 142
[35] COX-2 inhibition
Varrassi, G
Facchetti, G
Marinangeli, F
MANAGEMENT OF ACUTE AND CHRONIC PAIN: THE USE OF THE TOOLS OF THE TRADE, 2000, : 351 - 356
[36] USE OF A NOVEL NONSTEROIDAL ANTIINFLAMMATORY DRUG IN THE HORSE
HIGGINS, AJ
LEES, P
SEDGWICK, AD
BUICK, AR
CHURCHUS, R
EQUINE VETERINARY JOURNAL, 1987, 19 (01) : 60 - 66
[37] Inhibition of sweet taste by the nonsteroidal antiinflammatory drug ibuprofen
Harmon, Payton C.
Deng, Daiyong
Sywanycz, Sarah M.
Hanselman, Emily C.
Breslin, Paul A. S.
CHEMICAL SENSES, 2022, 47
[38] Cardiovascular effects of selective COX-2 inhibition: Is there a class effect? The international COX-2 study group
Crofford, Leslie J.
Breyer, Matthew D.
Strand, C. Vibeke
Rushitzka, Frank
Brune, Kay
Farkouh, Michael E.
Simon, Lee S.
JOURNAL OF RHEUMATOLOGY, 2006, 33 (07) : 1403 - 1408
[39] Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
Hermanson, Daniel J.
Gamble-George, Joyonna C.
Marnett, Lawrence J.
Patel, Sachin
TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (07) : 358 - 367
[40] The David Y. Graham lecture: Use of nonsteroidal Antiinflammatory drugs in a COX-2 restricted environment
Chan, Francis K. L.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (01) : 221 - 227

← 1 2 3 4 5 →